| Income Statement |
| Total Revenue | 291.95M |
|
| Revenues (USD) | 291.95M |
| Cost of Revenue | 145.56M |
| Gross Profit | 146.39M |
| Operating Expenses | 112.88M |
| Research and Development Expense | 35.10M |
| Selling, General and Administrative Expense | 52.87M |
| Operating Income | 33.51M |
| Income Tax Expense | 4.30M |
| Net Income | 33.75M |
| Net Income Common Stock | 33.75M |
| Net Income Common Stock (USD) | 33.75M |
| Consolidated Income | 33.75M |
| Earnings per Basic Share | 0.68 |
| Earnings per Basic Share (USD) | 0.68 |
| Earnings per Diluted Share | 0.67 |
| Earning Before Interest & Taxes (EBIT) | 38.05M |
| Earning Before Interest & Taxes (USD) | 38.05M |
| Weighted Average Shares | 49.74M |
| Weighted Average Shares Diluted | 50.00M |
| Balance Sheet |
| Cash and Equivalents | 252.25M |
| Cash and Equivalents (USD) | 252.25M |
| Investments | 401.92M |
| Investments Current | 401.92M |
| Trade and Non-Trade Receivables | 306.56M |
| Current Assets | 1.32B |
| Property, Plant & Equipment Net | 123.82M |
| Total Assets | 2.40B |
| Current Liabilities | 214.45M |
| Total Liabilities | 264.18M |
| Accumulated Retained Earnings (Deficit) | 777.54M |
| Accumulated Other Comprehensive Income | -12.54M |
| Shareholders Equity | 2.13B |
| Shareholders Equity (USD) | 2.13B |
| Assets Non-Current | 1.08B |
| Deferred Revenue | 31.44M |
| Goodwill and Intangible Assets | 921.87M |
| Inventory | 316.03M |
| Liabilities Non-Current | 49.73M |
| Trade and Non-Trade Payables | 105.52M |
| Tax Assets | 4.45M |
| Tax Liabilities | 20.27M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 25.48M |
| Net Cash Flow from Financing | -6.70M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -93.87M |
| Capital Expenditure | -3.58M |
| Net Cash Flow from Investing | -112.61M |
| Net Cash Flow - Investment Acquisitions and Disposals | -109.02M |
| Net Cash Flow from Operations | 26.32M |
| Effect of Exchange Rate Changes on Cash | -887.00K |
| Share Based Compensation | 7.01M |